SCIENTIFIC DASHBOARD
Clinical features of COVID-19 in Pediatric Patients (COPP)
This live dashboard displays figures and tables based on the data collected in the COPP study.
Information on the live scientific dashboard
Data managament
The data for this live dashboard is being collected for the COPP study. The figures and tables are automatically generated from electronic case record files. Data control and monitoring is continuous. We will publish regular updates to this page. Data is updated every day at 12:00.
Inclusion criteria for the COPP study are:
- Age 0-17 years
- Presentation in Dutch hospital (in- or outpatient) participating in our study
- Evidence of current SARS-CoV-infection and/or MIS-C
- Informed consent by patient and/or caregiver
Realisation: Anne Verbeek en Erik von Asmuth
Table 1a. Patient characteristics by clinical syndrome
Excluded: second presentation of same patient, patients with missing clinical syndrome.
|
1
Median (IQR); n (%)
2
Kruskal-Wallis rank sum test; Pearson's Chi-squared test
|
|||||||
3. Roede MJ & van Wieringen JC, bewerking TNO (1985) Growth diagrams 1980: Netherlands third nation-wide survey. Tijdschrift voor Sociale Gezondheidszorg, 63, 1-34.
Table 1b. Patient characteristics by disease severity
Excluded: second presentation of same patient, patients with missing clinical syndrome, patients with missing disease severity, asymptomatic patients.
|
1
Median (IQR); n (%)
2
Kruskal-Wallis rank sum test; Pearson's Chi-squared test
|
||||||||
3. Roede MJ & van Wieringen JC, bewerking TNO (1985) Growth diagrams 1980: Netherlands third nation-wide survey. Tijdschrift voor Sociale Gezondheidszorg, 63, 1-34.
Definitions severity for COVID-19:
Asymptomatic: no signs or symptoms attributable to SARS-CoV-2 infection
Non-severe: no supplemental oxygen;
Moderately severe: supplemental oxygen, no ICU admission
Severe: ICU admission
Very severe: ECMO and/or died
Definitions severity for MIS-C:
Non-severe: no ICU admission;
Moderately severe: ICU admission, but no invasive respiratory support and/or inotropic support
Severe: ICU admission with invasive respiratory support and/or inotropic support
Very severe: ECMO and/or died
Figure 1. Children with COVID-19
Number of children with COVID-19 included in the COPP-study.
Excluded: second presentation of same patient, patients with missing clinical syndrome.
Figure 2. Map of residence of children included in the study
These numbers are based on the amount of patients included in the COPP study. For the national numbers, see the RIVM website.
© Kadaster / Centraal Bureau voor de Statistiek, 2013
Table 2a. Medical History by clinical syndrome
Excluded: second presentation of same patient, patients with missing clinical syndrome, patients with missing medical history.
|
1
n/N (%)
2
Fisher's exact test
|
||||||
Due to the near-real time reporting, data on some variables is incomplete. This results in different denominators of the fractions.
Table 2b. Medical History by disease severity
Excluded: second presentation of same patient, patients with missing clinical syndrome, patients with missing disease severity, patients with missing medical history.
|
1
n/N (%)
2
Fisher's exact test
|
||||||
Figure 3. Age of patients per clinical syndrome
By gender.
Excluded: second presentation of same patient, patients with missing clinical syndrome, patients with missing gender, patients with missing age.
COVID-19 with respiratory symptoms
Aspecific signs and symptoms attributed to COVID-19
Multisystem Inflammatory Syndrome in Children
Age distribution of patients from all clinical syndrome categories
Screening and/or symptoms not attributed to COVID-19
Figure 4. Most common presenting symptoms
By clinical syndrome.
Excluded: second presentation of same patient, electronic case record files with less than 90% progress, patients with missing clinical syndrome, patients within screening group, patients of whom symptoms were not attributed to COVID-19, patients with missing symptoms.
Table 3. Treatment of MIS-C
Included: MIS-C patients, records with at least 90% completion.
Excluded: second presentation of same patient, patients with missing clinical syndrome, patients with missing disease severity, asymptomatic patients.
|
1
n/N (%)
|
|||
Figure 5. Lymphopenia by age group
Lymphopenia defined as a lymphocyte count below the age-specific threshold at presentation or during admission.
Excluded: patients with missing age, patients without lymphocyte count available, patients with missing clinical syndrome, patients from screening and/or symptoms not attributed to COVID-19 group.
